Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7288)
All Articles published online
|
Publishing Process of This Article
|
Apr 28, 2019 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Qi SX, Sun H, Liu H, Yu J, Jiang ZY, Yan P. Role and mechanism of circ-PRKCI in hepatocellular carcinoma. World J Gastroenterol 2019; 25(16): 1964-1974 [PMID: 31086464 DOI: 10.3748/wjg.v25.i16.1964] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i16/1964.htm |
| Number | Citing Articles |
| 1 |
Yanni Sun, Xiuxiang Sun, Qingxian Huang. Circ_0000105 promotes liver cancer by regulating miR‐498/PIK3R1. The Journal of Gene Medicine 2020; 22(11) doi: 10.1002/jgm.3256
|
| 2 |
Fei Teng, Ju-Xiang Zhang, Qi-Meng Chang, Xu-Bo Wu, Wei-Guo Tang, Jian-Fa Wang, Jin-Feng Feng, Zi-Ping Zhang, Zhi-Qiu Hu. LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research 2020; 39(1) doi: 10.1186/s13046-020-01739-z
|
| 3 |
Tae-Su Han, Keun Hur, Hyun-Soo Cho, Hyun Seung Ban. Epigenetic Associations between lncRNA/circRNA and miRNA in Hepatocellular Carcinoma. Cancers 2020; 12(9): 2622 doi: 10.3390/cancers12092622
|
| 4 |
Yao Zhang, Yu Chen, Yue Wan, Yueshui Zhao, Qinglian Wen, Xiaolong Tang, Jing Shen, Xu Wu, Mingxing Li, Xiang Li, Jing Li, Wanping Li, Zhangang Xiao, Fukuan Du. Circular RNAs in the Regulation of Oxidative Stress. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.697903
|
| 5 |
Hongwu Meng, Ruowen Niu, Cheng Huang, Jun Li. Circular RNA as a Novel Biomarker and Therapeutic Target for HCC. Cells 2022; 11(12): 1948 doi: 10.3390/cells11121948
|
| 6 |
Mostafa K. Abd El‐Aziz, Alyaa Dawoud, Caroline J. Kiriacos, Sherif Ashraf Fahmy, Nadia M. Hamdy, Rana A. Youness. Decoding hepatocarcinogenesis from a noncoding RNAs perspective. Journal of Cellular Physiology 2023; 238(9): 1982 doi: 10.1002/jcp.31076
|
| 7 |
A. Dawoud, R.A. Elmasri, A.H. Mohamed, A. Mahmoud, M.M. Rostom, R.A. Youness. Involvement of CircRNAs in regulating The “New Generation of Cancer Hallmarks”: A Special Depiction on Hepatocellular Carcinoma. Critical Reviews in Oncology/Hematology 2024; 196: 104312 doi: 10.1016/j.critrevonc.2024.104312
|
| 8 |
Meiliang Liu, Mingshuang Lai, Deyuan Li, Ruirui Zhang, Lijun Wang, Wenyi Peng, Jialei Yang, Wanting He, Yonghong Sheng, Suyang Xiao, Aruo Nan, Xiaoyun Zeng. Nucleus‐localized circSLC39A5 suppresses hepatocellular carcinoma development by binding to STAT1 to regulate TDG transcription. Cancer Science 2023; 114(10): 3884 doi: 10.1111/cas.15906
|
| 9 |
Xiang-Kun Wang, Yu-Xiang Guo, Miao Wang, Xu-Dong Zhang, Zhong-Yuan Liu, Mao-Sen Wang, Kai Luo, Shuai Huang, Ren-Feng Li. Identification and validation of candidate clinical signatures of apolipoprotein L isoforms in hepatocellular carcinoma. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-48366-0
|
| 10 |
Liheng Li, Chengjiang Xiao, Ke He, Guoan Xiang. Circ_0072088 promotes progression of hepatocellular carcinoma by activating JAK2/STAT3 signaling pathway via miR‐375. IUBMB Life 2021; 73(9): 1153 doi: 10.1002/iub.2520
|
| 11 |
Li-Yun Fu, Shu-Wei Wang, Meng-Yuan Hu, Zhen-Luo Jiang, Li-Li Shen, Yu-Ping Zhou, Jun-Ming Guo, Yao-Ren Hu. Circular RNAs in liver diseases: Mechanisms and therapeutic targets. Life Sciences 2021; 264: 118707 doi: 10.1016/j.lfs.2020.118707
|
| 12 |
Ye-Ru Tan, Bao-Hong Jiang, Wen-Jie Feng, Zhi-Long He, Yi-Ling Jiang, Yi Xun, Xiao-Ping Wu, Yue-Hua Li, Hong-Bo Zhu. Circ0060467 sponges miR-6805 to promote hepatocellular carcinoma progression through regulating AIFM2 and GPX4 expression. Aging 2024; 16(2): 1796 doi: 10.18632/aging.205460
|
| 13 |
Xiaofeng Shi, Wei Ma, Yongqi Li, Han Wang, Shuang Pan, Yongquan Pan, Caiming Xu, Lei Li. CircPRKCI relieves lipopolysaccharide‐induced HK2 cell injury by upregulating the expression of miR‐545 target gene ZEB2. BioFactors 2020; 46(3): 475 doi: 10.1002/biof.1620
|
| 14 |
Yuefeng Ma, Danjie Zhang, Hua Wu, Pengfei Li, Wen Zhao, Xiaoping Yang, Xin Xing, Shaomin Li, Jianzhong Li. Circular RNA PRKCI silencing represses esophageal cancer progression and elevates cell radiosensitivity through regulating the miR-186-5p/PARP9 axis. Life Sciences 2020; 259: 118168 doi: 10.1016/j.lfs.2020.118168
|
| 15 |
Lipeng Qiu, Han Xu, Mengchen Ji, Dongsheng Shang, Ziwen Lu, Yihang Wu, Zhigang Tu, Hanqing Liu. Circular RNAs in hepatocellular carcinoma: Biomarkers, functions and mechanisms. Life Sciences 2019; 231: 116660 doi: 10.1016/j.lfs.2019.116660
|
| 16 |
Hongmu Zhou, Ying Chen. CircRNA has_circ_0001806 promotes hepatocellular carcinoma progression via the miR-193a-5p/MMP16 pathway. Brazilian Journal of Medical and Biological Research 2021; 54(12) doi: 10.1590/1414-431x2021e11459
|
| 17 |
Xuebang Zhang, Han Yang, Lihao Zhao, Gang Li, Yuxia Duan. Circular RNA PRKCI promotes glioma cell progression by inhibiting microRNA-545. Cell Death & Disease 2019; 10(8) doi: 10.1038/s41419-019-1863-z
|
| 18 |
Bohua Wei, Li Yu. Circular RNA PRKCI and microRNA-545 relate to sepsis risk, disease severity and 28-day mortality. Scandinavian Journal of Clinical and Laboratory Investigation 2020; 80(8): 659 doi: 10.1080/00365513.2020.1827291
|
| 19 |
Zhongyue Liu, Xiaolei Ren, Zhimin Yang, Lin Mei, Wenyi Li, Chao Tu, Zhihong Li. Prognostic and clinical value of circPRKCI expression in diverse human cancers. Chinese Medical Journal 2024; 137(2): 152 doi: 10.1097/CM9.0000000000002844
|
| 20 |
Xiong Wang, Huijun Li, Yanjun Lu, Liming Cheng. Circular RNAs in Human Cancer. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.577118
|
| 21 |
Shipei Qiu, Kefan Zhang, Siyu Chen, Shuting Yin. Circular RNA PRKCI (hsa_circ_0067934): a potential target in the pathogenesis of human malignancies. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1365032
|